Stockreport

Coya Therapeutics Issues Letter to Stockholders Highlighting Expansion of COYA 302 into Alzheimer's Disease and Coya's Pathway to a "Pipeline in a Product" [Yahoo! Finance]

Coya Therapeutics, Inc.  (COYA) 
PDF Expansion of COYA 302 into Alzheimer's Disease leverages synergistic mode of action and intellectual property position of the biologic combination of the Company's prop [Read more]